Partnership for Safe Medicines Executive Director Speaks at Brazil Counterfeit Drug Forum

Washington, D.C. (October 17, 2011) – Addressing the growing public health crisis posed by counterfeit medicines in Brazil requires the coordinated effort of all stakeholders across the country, said Partnership for Safe Medicines Executive Director Scott LaGanga during a forum today in Rio de Janeiro on counterfeit medicines hosted by Interfarma and Brazilian newspaper O…

[...]

Deputy Director of ICE Keynote Speaker for Interchange

Kumar C. Kibble will be the keynote speaker for The Partnership for Safe Medicine’s Interchange on October 27, 2011 at the National Press Club.

Kumar C. Kibble is the deputy director for U.S. Immigration and Customs Enforcement (ICE). In that capacity, he is the chief operating officer for the principal investigative agency of the Department of Homeland Security, with more than 20,000 employees assigned to more than 400 offices worldwide and an annual budget of almost $6 billion.

[...]

IAPO Seminar in Manilla Raises Awareness of Unsafe Medications

The International Alliance of Patients’ Organizations (IAPO) conducted a seminar to build better understanding of patients needs in Pacific-Asia including the risks of counterfeit medications. “Patients should be the local leaders of a whole of society approach to tackling the pressing healthcare challenges of today,” announced IAPO at the seminar in Manilla, Philippines. The IAPO…

[...]

Xuanhao Chan To Speak On Panel at Interchange

Xuanhao Chan, lead technical officer for the International Pharmaceutical Federation, will join panelists on “The role of Patients and Healthcare Professionals” at the Partnership for Safe Medicine Interchange on October 27, 2011.

Chan is a registered pharmacist from Singapore and for the past 6 years, he has been working for the International Pharmaceutical Federation (FIP) in various positions. More recently, in 2008 he established the first branch office for FIP in Geneva managing the Federation’s global public health partnerships and serves as the FIP advocacy focal point with the World Health Organization (WHO) and other international health-related agencies in Geneva, Switzerland.

[...]

Lilly, Sponsor of the Partnership for Safe Medicines Interchange 2011

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs. Learn more about…

[...]

India Takes Strong Stance on Spurious Medicines

Bejon Misra, FounderThe Partnership for Safe Medicines India With 80-90% of anti-malarial and anti-retro viral drugs world wide produced in India, Indian officials and manufacturers are combining efforts to crack down on spurious medicine producers that kill 100,000 people in Africa annually . Paul Lavlani, Dean of the Empower School of Health, says that $5bn…

[...]

NABP Reminds Indiana To Verify Online Pharmacy Before Buying

Indianapolis reporter Rafael Sanchez reports that bargain medications purchased online don’t come with a “danger disclaimer.” Reporting for 6News Indianapolis, Sanchez spoke with the National Association of Boards of Pharmacy executive director Carmen Catizone, about the risks involved with purchasing medications from unlicensed fake pharmacies online. Said Catizone, “We found rat poison, lead paint, [and]…

[...]

Sproxil, Sponsor of the Partnership for Safe Medicines Interchange

Sproxil provides world-class brand protection for emerging markets through software and services that work anywhere there are mobile phones. Delivering automatic protection, simple labels and robust back-end analytics with its Mobile Product AuthenticationTM (MPA) solution, Sproxil offers a comprehensive anti-counterfeiting strategy for cash-based societies, one that enables consumers to text message an item-unique code for…

[...]

Foreign Medicines Poses a Risk to Chronically Ill Americans

The Partnership for Safe Medicines (PSM) released a new report this week, A Risky Proposition: How Opening the U.S. to Foreign Medicines Poses a Risk to Chronically Ill Americans, detailing the dangers posed to American patients by opening up the secure and safe U.S. medical supply chain to foreign drugs through importation.   We released this latest…

[...]